| RS1554334872 |
GCK
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS1554334886 |
GCK
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS1554334894 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young type 2 |
| RS1554334905 |
GCK
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS1554335093 |
GCK
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS1554335109 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1554335111 |
GCK
|
Health Risk |
Pathogenic |
Monogenic diabetes, Maturity-onset diabetes of the young |
| RS1554335128 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1554335132 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS1554335135 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1554335141 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1554335164 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young type 2 |
| RS1554335391 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS1554335400 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1554335417 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Maturity-onset diabetes of the young |
| RS1554335418 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1554335421 |
GCK
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS1554335441 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS1554335444 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1554335461 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS1554335482 |
CDK13
|
Health Risk |
Likely pathogenic |
— |
| RS1554335512 |
CDK13
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Syndromic intellectual disability |
| RS1554335560 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1554335564 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS1554335566 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS1554335567 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1554335570 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Type 2 diabetes mellitus |
| RS1554335573 |
GCK
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS1554335585 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1554335596 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1554335598 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1554335616 |
GCK
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS1554335741 |
GCK
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1554335751 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young type 2 |
| RS1554335752 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS1554335758 |
GCK
|
Health Risk |
Uncertain risk allele |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS1554335761 |
GCK
|
Health Risk |
Likely pathogenic |
— |
| RS1554335913 |
GCK
|
Health Risk |
Pathogenic |
— |
| RS1554335926 |
PEX7
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 1, Rhizomelic chondrodysplasia punctata type 1 |
| RS1554335937 |
PEX7
|
Health Risk |
Pathogenic |
Rhizomelic chondrodysplasia punctata type 1, Peroxisome biogenesis disorder 9B |
| RS1554335954 |
GCK
|
Health Risk |
Likely risk allele |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS1554335966 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS1554336974 |
SAMD9
|
Health Risk |
Pathogenic/Likely pathogenic |
MIRAGE syndrome, MIRAGE syndrome |
| RS1554336981 |
SAMD9
|
Health Risk |
Pathogenic |
Inborn genetic diseases, MIRAGE syndrome |
| RS1554337067 |
SAMD9
|
Health Risk |
Conflicting classifications of pathogenicity |
SAMD9-related disorder, SAMD9-related disorder |
| RS1554337369 |
GARS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 2 |
| RS1554337424 |
SAMD9
|
Health Risk |
Likely pathogenic |
Normophosphatemic familial tumoral calcinosis, Normophosphatemic familial tumoral calcinosis |
| RS1554337974 |
GARS1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease |
| RS1554338016 |
AHI1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1554338260 |
GARS1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease |
| RS1554338262 |
GARS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Spinal muscular atrophy |
| RS1554338264 |
GARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1554338272 |
GARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 2 |
| RS1554338641 |
GARS1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1554340243 |
RMND1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554341061 |
SBDS
|
Health Risk |
Likely pathogenic |
— |
| RS1554341158 |
SAMD9L
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-pancytopenia syndrome, Monosomy 7 myelodysplasia and leukemia syndrome 1 |
| RS1554341277 |
SAMD9L
|
Health Risk |
Pathogenic |
Ataxia-pancytopenia syndrome, Ataxia-pancytopenia syndrome |
| RS1554341671 |
SAMD9L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Spinocerebellar ataxia 49 |
| RS1554343985 |
SGCE
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Myoclonic dystonia 11 |
| RS1554345052 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS1554345077 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS1554345124 |
SGCE
|
Health Risk |
Pathogenic |
— |
| RS1554345162 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS1554345170 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS1554345179 |
SGCE
|
Health Risk |
Likely pathogenic |
— |
| RS1554345208 |
SGCE
|
Health Risk |
Likely pathogenic |
— |
| RS1554347012 |
AHI1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis, Leber congenital amaurosis |
| RS1554350366 |
EGFR
|
Health Risk |
Likely pathogenic |
Non-small cell lung carcinoma, Non-small cell lung carcinoma |
| RS1554350382 |
EGFR
|
Health Risk |
Likely pathogenic |
Lung adenocarcinoma, Lung adenocarcinoma |
| RS1554350503 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS1554350554 |
ASNS
|
Health Risk |
Likely pathogenic |
Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome, Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome |
| RS1554350586 |
ASNS
|
Health Risk |
Likely pathogenic |
— |
| RS1554352234 |
SLC26A4
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 4, Autosomal recessive nonsyndromic hearing loss 4 |
| RS1554352240 |
SLC26A4
|
Health Risk |
Likely pathogenic |
Pendred syndrome, Autosomal recessive nonsyndromic hearing loss 4 |
| RS1554352676 |
SLC26A4
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 4, Autosomal recessive nonsyndromic hearing loss 4 |
| RS1554352718 |
SLC26A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Pendred syndrome, Autosomal recessive nonsyndromic hearing loss 4 |
| RS1554352819 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS1554352906 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS1554352952 |
SGCE
|
Health Risk |
Pathogenic/Likely pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS1554353106 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS1554353948 |
SLC25A13
|
Health Risk |
Likely pathogenic |
— |
| RS1554354787 |
SLC26A4
|
Health Risk |
Pathogenic |
Pendred syndrome, Autosomal recessive nonsyndromic hearing loss 4 |
| RS1554354801 |
SLC26A4
|
Health Risk |
Likely pathogenic |
Pendred syndrome, Pendred syndrome |
| RS1554355011 |
SLC26A4
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 4, Autosomal recessive nonsyndromic hearing loss 4 |
| RS1554355416 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS1554357206 |
SLC26A4
|
Health Risk |
Likely pathogenic |
Pendred syndrome, Pendred syndrome |
| RS1554357231 |
SLC26A4
|
Health Risk |
Pathogenic |
Pendred syndrome, Autosomal recessive nonsyndromic hearing loss 4 |
| RS1554358639 |
SGCE
|
Health Risk |
Conflicting classifications of pathogenicity |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS1554358720 |
SLC26A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Hearing loss, autosomal recessive |
| RS1554358727 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS1554359569 |
CFAP69
|
Health Risk |
Pathogenic |
Spermatogenic failure 24, Spermatogenic failure 24 |
| RS1554359670 |
SLC26A4
|
Health Risk |
Likely pathogenic |
Pendred syndrome, Autosomal recessive nonsyndromic hearing loss 4 |
| RS1554359685 |
CFAP69
|
Health Risk |
Pathogenic |
Spermatogenic failure 24, Spermatogenic failure 24 |
| RS1554359693 |
SLC26A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Pendred syndrome, Autosomal recessive nonsyndromic hearing loss 4 |
| RS1554360358 |
SLC26A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 4, Pendred syndrome |
| RS1554360678 |
SLC26A4
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 4, Autosomal recessive nonsyndromic hearing loss 4 |
| RS1554360707 |
SLC26A4
|
Health Risk |
Likely pathogenic |
Pendred syndrome, Autosomal recessive nonsyndromic hearing loss 4 |
| RS1554360816 |
SLC26A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 4, Autosomal recessive nonsyndromic hearing loss 4 |
| RS1554360841 |
SLC26A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Pendred syndrome, Autosomal recessive nonsyndromic hearing loss 4 |